BILLERICA, Mass. (AP) _ Insulet Corp. (PODD) on Monday reported a loss of $9.1 million in its fourth quarter.
On a per-share basis, the Billerica, Massachusetts-based company said it had a loss of 16 cents.
The results did not meet Wall Street expectations. The average estimate of 15 analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.
The maker of insulin infusion systems posted revenue of $103.6 million in the period, which beat Street forecasts. Eleven analysts surveyed by Zacks expected $100.7 million.
For the year, the company reported that its loss narrowed to $28.9 million, or 50 cents per share. Revenue was reported as $367 million.
For the current quarter ending in April, Insulet said it expects revenue in the range of $96 million to $99 million.
The company expects full-year revenue in the range of $420 million to $440 million.
Insulet shares have climbed 23 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $46.17, a climb of 57 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PODD at https://www.zacks.com/ap/PODD
Keywords: Insulet, Earnings Report